The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: A randomised controlled trial (ISRCTN96071600)

British Journal of Cancer

Volumn 104, Issue 2, 2011, Pages 248-254

  Giorgi Rossi, P ^a   Marsili, L M ^b   Camilloni, L ^a   Iossa, A ^c   Lattanzi, A ^d   Sani, C ^c   Di Pierro, C ^c   Grazzini, G ^c   Angeloni, C ^d   Capparucci, P ^b   Pellegrini, A ^e   Schiboni, M L ^e   Sperati, A ^a   Confortini, M ^c   Bellanova, C ^b   D'Addetta, A ^b   Mania, E ^b   Visioli, C B ^c   Sereno, E ^c   Carozzi, F ^c  

^a Agency for Public Health   (Italy)

^b ASL Roma B   (Italy)

^c ISPO   (Italy)

^d Ospedale di Atri   (Italy)

^e MOLINETTE HOSPITAL   (Italy)

Author keywords

cervical cancer prevention; HPV test; Pap test; screening programme

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; FEMALE; GROUPS BY AGE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MASS SCREENING; MULTICENTER STUDY; PAPANICOLAOU TEST; POSTAL MAIL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFUSAL TO PARTICIPATE; RURAL AREA; SERODIAGNOSIS; UTERINE CERVIX CANCER; WART VIRUS; WART VIRUS TESTING;

ADULT; ALPHAPAPILLOMAVIRUS; FEMALE; HUMANS; ITALY; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 78751541434     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6606040     Document Type: Article

References (41)

1. Anhang R, Nelson JA, Telerant R, Chiasson MA, Wright Jr TC (2005) Acceptability of self-collection of specimens for HPV DNA testing in an urban population. Womens Health (Larchmt) 14: 721-728
2. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, Wiener H, Herbert A, von Karsa L (2008) European Guidelines for Quality Assurance on Cervical Cancer Screening 2nd edn. European Community: Brussels; Office for Official Publications of the European Communities: Luxembourg
3. Bauer HM, Greer CE, Manos MM (1992) Determination of genital human papillomavirus infection by consensus polymerase chain reaction amplification. In Diagnostic Molecular Pathology, A Practical Approach, Herrington CS, McGee JOD (eds), pp 131-152. IRL Press: Oxford, UK
4. Belinson JL, Qiao YL, Pretorius RG, Zhang WH, Rong SD, Huang MN, Zhao FH, Wu LY, Ren SD, Huang RD, Washington MF, Pan QJ, Li L, Fife D (2003) Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. Int J Gynecol Cancer 13: 819-826
5. Bos AB, Rebolj M, Habbema JD, Van Ballegooijen M (2006) Non-attendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer 119: 2372-2375
6. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V, WHO International Agency for Research on Cancer Monograph Working Group (2009) A review of human carcinogens - Part B: biological agents. Lancet Oncol 10: 321-322
7. Brink AA, Meijer CJ, Wiegerinck MA, Nieboer TE, Kruitwagen RF, Van Kemenade F, Fransen Daalmeijer N, Hesselink AT, Berkhof J, Snijders PJ (2006) High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush. J Clin Microbiol 44: 2518-2523
8. Bulkmans NW, Berkhof J, Rozendaal L, Van Kemenade FJ, Boeke AJ, Bulk S, Voorhorst FJ, Verheijen RH, Van Groningen K, Boon ME, Ruitinga W, Van Ballegooijen M, Snijders PJ, Meijer CJ (2007) Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 370: 1764-1772
9. Ciatto S, Grazzini G, Cecchini S, Iossa A (1993) Screening history of incident cases of invasive carcinoma of the cervix. Florence district 1988-1989. Tumori 79: 311-313
10. Corkrey R, Parkinson L, Bates L (2005) Pressing the key pad: trial of a novel approach to health promotion advice. Prev Med 41: 657-666
11. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, Dillner J, Meijer CJ (2008) Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 26: K29-K41
12. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T (2006) Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119: 1095-1101
13. Eaker S, Adami HO, Granath F, Wilander E, Sparén P (2004) A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev 13: 346-354
14. Giorgi Rossi P, Brezzi S, Esposito G, Brachini A, Raggi P, Federici A (2006) Estimation of Pap-test coverage in an area with an organised screening program: challenges for survey methods. BMC Health Ser Res 6: 36
15. Gök M, Heideman DA, Van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JW, Voorhorst F, Beliën JA, oviæ M, Snijders PJ, Meijer CJ (2010) HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 340: c1040
16. IARC Working Group on the Evaluation of Cancer Preventive Strategies 2005) Cervix Cancer Screening. IARC Handbooks of Cancer Prevention. IARC: Lyon.
17. Ingemann-Hansen O, Lidang M, Niemann I, Dinesen J, Baandrup U, Svanholm H, Petersen L (2008) Screening history of women with cervical cancer: a 6-year study in Aarhus, Denmark. Br J Cancer 98: 1292-1294
18. ISTAT (2006) La prevenzione dei tumori femminili in Italia: il ricorso a pap test e mammografia. Anni 2004-2005. ISTAT: Roma (available at: http:// www.istat.it/salastampa/comunicati/non-calendario/20061204-00/)
19. Janerich DT, Hadjimichael O, Schwartz PE, Lowell DM, Meigs JW, Merino MJ, Flannery JT, Polednak AP (1995) The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health 85: 791-794
20. Jensen H, Svanholm H, Støvring H, Bro F (2009) A primary healthcare-based intervention to improve a Danish cervical cancer screening programme: a cluster randomised controlled trial. J Epidemiol Community Health 63: 510-515
21. Leyden WA, Manos MM, Geiger AM, Weinmann S, Mouchawar J, Bischoff K, Yood MU, Gilbert J, Taplin SH (2005) Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst 97: 675-683
22. Morrell S, Taylor R, Wain G (2005) A study of Pap test history and histologically determined cervical cancer in NSW women, 1997-2003. J Med Screen 12: 190-196
23. Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Radberg T, Strander B, Johansson B, Forslund O, Hansson BG, Rylander E, Dillner J (2007) Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 357: 1589-1597
24. Nobbenhuis MA, Helmerhorst TJ, Van den Brule AJ, Rozendaal L, Jaspars LH, Voorhorst FJ, Verheijen RH, Meijer CJ (2002) Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol 55: 435-439
25. Ogilvie G, Krajden M, Maginley J, Isaac-Renton J, Hislop G, Elwood-Martin R, Sherlock C, Taylor D, Rekart M (2007) Feasibility of self-collection of specimens for human papillomavirus testing in hard-to-reach women. CMAJ 177: 480-483
26. PASSI (2009) Sistema di sorveglianza PASSI. Rapporto nazionale 2008. Iacobelli: Pavona (available at: http://www.epicentro.iss.it/passi/ )
27. Petignat P, Faltin DL, Bruchim I, Tramèr MR, Franco EL, Coutlée F (2007) Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 105: 530-535
28. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, Rizzolo R, Schincaglia P, Zorzi M, Zappa M, Segnan N, Cuzick J, New Technologies for Cervical Cancer screening (NTCC) Working Group (2010) Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 11: 249-257
29. Ronco G, Giubilato P, Naldoni C, Zorzi M, Anghinoni E, Scalisi A, Dalla Palma P, Zanier L, Barca A, Angeloni C, Prandini S, Maglietta R, Mancini E, Pizzuti R, Iossa A, Segnan N, Zappa M (2008) Extension of organised cervical cancer screening programmes in Italy and their process indicators. Epidemiol Prev 32: 37-54
30. Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J, New Technologies for Cervical Cancer Working Group (2006) Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst 98: 765-774 (Pubitemid 43983300)
31. Salmerón J, Lazcano-Ponce E, Lorincz A, Hernández M, Hernández P, Leyva A, Uribe M, Manzanares H, Antunez A, Carmona E, Ronnett BM, Sherman ME, Bishai D, Ferris D, Flores Y, Yunes E, Shah KV (2003) Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 14: 505-512
32. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, Hingmire S, Malvi SG, Thorat R, Kothari A, Chinoy R, Kelkar R, Kane S, Desai S, Keskar VR, Rajeshwarkar R, Panse N, Dinshaw KA (2009) HPV screening for cervical cancer in rural India. N Engl J Med 360: 1385-1394
33. Sanner K, Wikström I, Strand A, Lindell M, Wilander E (2009) Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer 101: 871-874
34. Sasieni PD, Cuzick J, Lynch-Farmery E (1996) Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer 73: 1001-1005
35. Stewart DE, Gagliardi A, Johnston M, Howlett R, Barata P, Lewis N, Oliver T, Mai V (2007) HPV Self-collection Guidelines Panel. Self-collected samples for testing of oncogenic human papillomavirus: a systematic review. J Obstet Gynaecol Can 29: 817-828
36. Sundhedsstyrelsen - Center for Evaluering og MTV (2005) Væskebaseret teknik og udstrygningsteknik anvendt til screening for livmoderhalskræft i Danmark: en medicinsk teknologivurdering. Report No. 7(3). Sundheds-styrelsen - Center for Evaluering og Medicinsk Teknologivurdering: København
37. Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA (2000) Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer 88: 2283-2289
38. Szarewski A, Cadman L, Mallett S, Austin J, Londesborough P, Waller J, Wardle J, Altman DG, Cuzick J (2007) Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting. J Med Screen 14: 34-42
39. Van der Graaf Y, Zielhuis GA, Peer PG, Vooijs PG (1988) The effectiveness of cervical screening: a population-based case-control study. J Clin Epidemiol 41: 21-26
40. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Austin J, Wardle J (2006) Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen 13: 208-213
41. Wright Jr TC, Denny L, Kuhn L, Pollack A, Lorincz A (2000) HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 283: 81-86